Grapefruit juice has minimal effects on centrations of lovastatin-derived plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsROGERS, J. D; JAMIE ZHAO; LIDA LIU et al.Clinical pharmacology and therapeutics. 1999, Vol 66, Num 4, pp 358-366, issn 0009-9236Article

Determination of MK-0476 in human plasma by liquid chromatographyAMIN, R. D; HAIYUNG CHENG; ROGERS, J. D et al.Journal of pharmaceutical and biomedical analysis. 1995, Vol 13, Num 2, pp 155-158, issn 0731-7085Article

Metabolic disposition of simvastatin in patients with T-tube drainageHAIYUNG CHENG; SCHWARTZ, M. S; OLAH, T. V et al.Drug metabolism and disposition. 1994, Vol 22, Num 1, pp 139-142, issn 0090-9556Article

The efficacy and six-week tolerability of simvastatin 80 and 160 mg/dayDAVIDSON, M. H; STEIN, E. A; DOBRINSKA, M. R et al.The American journal of cardiology. 1997, Vol 79, Num 1, pp 38-42, issn 0002-9149Article

Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatinHAIYUNG CHENG; ROGERS, J. D; SWEANY, A. E et al.Pharmaceutical research. 1992, Vol 9, Num 12, pp 1629-1633, issn 0724-8741Article

Metabolic profiles of montelukast sodium (singulair), a potent cysteinyl leukotriene₁ receptor antagonist, in human plasma and bileBALANI, S. K; XU, X; FREEMAN, A et al.Drug metabolism and disposition. 1997, Vol 25, Num 11, pp 1282-1287, issn 0090-9556Article

Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humansPENTIKAINEN, P. J; SARAHEIMO, M; SCHWARTZ, J. I et al.Journal of clinical pharmacology. 1992, Vol 32, Num 2, pp 136-140, issn 0091-2700Article